Rapid response to methylphenidate as an add-on therapy to mirtazapine in the treatment of major depressive disorder in terminally ill cancer patients:: A four-week, randomized, double-blinded, placebo-controlled study

C.G. Ng; M.P. Boks; K.C.B. Roes; N.Z. Zainal; A.H. Sulaiman; S. Tan; N.J. de Wit

Rapid response to methylphenidate as an add-on therapy to mirtazapine in the treatment of major depressive disorder in terminally ill cancer patients: A four-week, randomized, double-blinded, placebo-controlled study

Translated title of the contribution: Rapid response to methylphenidate as an add-on therapy to mirtazapine in the treatment of major depressive disorder in terminally ill cancer patients: A four-week, randomized, double-blinded, placebo-controlled study

C.G. Ng, M.P. Boks, K.C.B. Roes, N.Z. Zainal, A.H. Sulaiman, S. Tan, N.J. de Wit

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Rapid response to methylphenidate as an add-on therapy to mirtazapine in the treatment of major depressive disorder in terminally ill cancer patients: A four-week, randomized, double-blinded, placebo-controlled study
Original language	Undefined/Unknown
Pages (from-to)	491-498
Number of pages	8
Journal	European Neuropsychopharmacology
Volume	24
Issue number	4
Publication status	Published - 2014

Keywords

Econometric and Statistical Methods: General
Geneeskunde(GENK)
Medical sciences
Bescherming en bevordering van de menselijke gezondheid

Access to Document

http://www.ncbi.nlm.nih.gov/pubmed/24503279

Cite this

Ng, C. G., Boks, M. P., Roes, K. C. B., Zainal, N. Z., Sulaiman, A. H., Tan, S., & de Wit, N. J. (2014). Rapid response to methylphenidate as an add-on therapy to mirtazapine in the treatment of major depressive disorder in terminally ill cancer patients: A four-week, randomized, double-blinded, placebo-controlled study. European Neuropsychopharmacology, 24(4), 491-498. http://www.ncbi.nlm.nih.gov/pubmed/24503279

@article{9686373f5cd24499b106c0ff51de1e23,

title = "Rapid response to methylphenidate as an add-on therapy to mirtazapine in the treatment of major depressive disorder in terminally ill cancer patients:: A four-week, randomized, double-blinded, placebo-controlled study",

keywords = "Econometric and Statistical Methods: General, Geneeskunde(GENK), Medical sciences, Bescherming en bevordering van de menselijke gezondheid",

author = "C.G. Ng and M.P. Boks and K.C.B. Roes and N.Z. Zainal and A.H. Sulaiman and S. Tan and {de Wit}, N.J.",

year = "2014",

language = "Undefined/Unknown",

volume = "24",

pages = "491--498",

journal = "European Neuropsychopharmacology",

issn = "0924-977X",

publisher = "Elsevier",

number = "4",

}

Ng, CG, Boks, MP, Roes, KCB, Zainal, NZ, Sulaiman, AH, Tan, S & de Wit, NJ 2014, 'Rapid response to methylphenidate as an add-on therapy to mirtazapine in the treatment of major depressive disorder in terminally ill cancer patients: A four-week, randomized, double-blinded, placebo-controlled study', European Neuropsychopharmacology, vol. 24, no. 4, pp. 491-498. <http://www.ncbi.nlm.nih.gov/pubmed/24503279>

Rapid response to methylphenidate as an add-on therapy to mirtazapine in the treatment of major depressive disorder in terminally ill cancer patients: A four-week, randomized, double-blinded, placebo-controlled study. / Ng, C.G.; Boks, M.P.; Roes, K.C.B. et al.
In: European Neuropsychopharmacology, Vol. 24, No. 4, 2014, p. 491-498.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Rapid response to methylphenidate as an add-on therapy to mirtazapine in the treatment of major depressive disorder in terminally ill cancer patients:

T2 - A four-week, randomized, double-blinded, placebo-controlled study

AU - Ng, C.G.

AU - Boks, M.P.

AU - Roes, K.C.B.

AU - Zainal, N.Z.

AU - Sulaiman, A.H.

AU - Tan, S.

AU - de Wit, N.J.

PY - 2014

Y1 - 2014

KW - Econometric and Statistical Methods: General

KW - Geneeskunde(GENK)

KW - Medical sciences

KW - Bescherming en bevordering van de menselijke gezondheid

M3 - Article

SN - 0924-977X

VL - 24

SP - 491

EP - 498

JO - European Neuropsychopharmacology

JF - European Neuropsychopharmacology

IS - 4

ER -